INDP – indaptus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Indaptus Therapeutics (NASDAQ:INDP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
Form SCHEDULE 13D Indaptus Therapeutics, Filed by: Lazar David E.
Form 8-K Indaptus Therapeutics, For: Feb 26
Form 4 Indaptus Therapeutics, For: Feb 26 Filed by: Jabbour Jerome D
Form 3 Indaptus Therapeutics, For: Feb 26 Filed by: Jabbour Jerome D
Form 3 Indaptus Therapeutics, For: Feb 26 Filed by: McMurdo Matthew Charles
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.